Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin
To access this article, please choose from the options below
PII: S0953-6205(07)00353-6
doi:10.1016/j.ejim.2007.06.014
© 2007 European Federation of Internal Medicine. Published by Elsevier Inc. All rights reserved.
